论文信息 - IPVS Policy statement on safety of HPV vaccines - 字舞流文

IPVS Policy statement on safety of HPV vaccines

[1] L. Patton,et al. Human papillomavirus vaccine , 2018, Reactions Weekly.

[2] S. Kjaer,et al. An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015 , 2015, The Pediatric infectious disease journal.

[3] H. Svanström,et al. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system. , 2015, JAMA.

[4] A. Langer-Gould,et al. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. , 2014, JAMA neurology.

[5] Jenny Jeyarajah,et al. Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States , 2014, MMWR. Morbidity and mortality weekly report.

[6] P. Sparén,et al. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study , 2013, BMJ.

[7] L. Denny. Safety of HPV vaccination: a FIGO statement. , 2013, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[8] Who,et al. Human papillomavirus vaccines: WHO position paper. , 2009, Biologicals : journal of the International Association of Biological Standardization.